Continuing Education Credits

DIA 2017 brings together key thought leaders and innovators from industry, academia, regulatory and government agencies, health, patient, and philanthropic organizations from around the globe - and across all disciplines involved in the discovery, development, and life cycle management of health care products. DIA 2017 is intended to strengthen professionals’ understanding of the value of cross-discipline integration and to foster innovation for better health outcomes.

Learning Objectives

At the conclusion of DIA 2017, participants should be able to:

Compare the current regional regulatory and public policy environment pertaining to pharmaceuticals and related products
Discuss the regulatory and economic factors that impact the global biopharmaceutical industry
Recognize the challenges facing regulatory agencies and industry in research study design and statistical methodology
Identify relevant data, document, and systems standards and integration approaches; explain their impact on quality and end to end efficiency in data collection, management, submission, and approval processes for medical products
Describe the current and future scope of innovative technology, including wearables and other mobile devices, in the generation and collection of electronic source data in clinical research and post-market assessment to improve patient outcomes
Discuss the role of big data and analytics, their applications throughout the product life cycle, and their ethical, legal, and security implications for patient data
Identify legal, advertising, and marketing issues related to providing product information
Apply principles of risk assessment and management to development and post-market phases of new health care products
Summarize issues in safety reporting and data analysis regarding adverse events
Distinguish regional approaches to integration of evidence-based medicine and comparative effectiveness research into health care decision making
Describe current issues in designing and implementing clinical trials, including patient recruitment, site selection and management of multiregional clinical trials
Discuss the evolving role of medical affairs in the medical product development landscape
Identify current opportunities and challenges in the area of personalized medicine for disease treatment
Examine ways to provide appropriate support to the clinical trial process that will ultimately impact patient care

Specific learning objectives for each offering are found on the DIA 2017 website under the program description details and will be shown in all meeting rooms.

Select short courses and program offerings (including sessions, forums, and workshops) may be approved for AMA PRA Category 1 Credits™, pharmacy or nursing contact hours, Project Management Institute (PMI) professional development units (PDUs), or International Association for Continuing Education and Training continuing education units (CEUs). Continuing education credit information will be clearly identified in the final program and on the DIA 2017 website with the statement CME, Pharmacy, Nursing, or PMI PDUs. IACET continuing education units (CEUs) are offered for most program offerings. CE credits are not available for the Engage and Exchange sessions, the Innovation Theater presentations, or the Opening Plenary session.

Accreditation Council for Continuing Medical Education (ACCME)

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Postgraduate Institute for Medicine (PIM) and the Drug Information Association (DIA). PIM is accredited by the ACCME to provide continuing medical education for physicians.

The Postgraduate Institute for Medicine designates this live activity for a maximum of 16.25 AMA PRA Category 1 Credits^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Accreditation Council for Pharmacy Education (ACPE)

DIA is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Participants can earn up to 14.5 contact hours or 1.45 continuing education units (CEUs) for participating in the Annual Meeting program offerings.
American Nurses Credentialing Center (ANCC)
This educational activity for 16.25 contact hours is provided by PIM.

PIM is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

DIA has been reviewed and approved as a provider of project management training by the Project Management Institute (PMI).

Participants may receive up to 8.75 professional development units (PDUs) for attending the Annual Meeting program offerings.

All DIA designated PMI numbers for approved offerings are found on the DIA 2017 Annual Meeting website at DIAglobal.org/DIA2017CE and on each designated offering description.

The PMI Registered Education Provider logo is a registered mark of the Project Management Institute, Inc.
International Association for Continuing Education and Training (IACET)

DIA has been accredited as an Authorized Provider by the International Association for Continuing Education and Training (IACET).

As an IACET accredited provider, DIA offers CEUs for its programs that qualify under the ANSI/IACET Standard. DIA is authorized by IACET to offer up to 1.9 CEUs for this program.
Continuing Legal Education

For attorneys who would like to receive continuing legal education credits for attending DIA 2017, please complete your state’s application for credit and submit accordingly. If you require additional information, please contact CE@DIAglobal.org
Statements of Credit

Participants who would like to receive continuing education credit for DIA 2017 must scan their DIA name badge at each offering to record their attendance. Participants must scan their badges within 45 minutes for the 1.5 hour offerings, and 30 minutes for the 1.25 hour offerings. Participants who do not scan their badges within the allotted time will not be eligible to request the available continuing education credits for that offering. If a participant attends multiple offerings within the same timeframe, only the last scanned entry will be recorded.

Further instructions for requesting your statement of credit will be provided in the final program.
Disclaimer

Unless otherwise disclosed, DIA acknowledges that the statements made by speakers are their own opinion and not necessarily that of the organization they represent, or that of the DIA. Speakers, agenda, and CE information are subject to change without notice.

Recording of any DIA educational material in any type of media is prohibited without prior written consent from DIA.
Disclosure of Conflicts of Interest

The Postgraduate Institute for Medicine (PIM) and DIA require instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by PIM and DIA for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. Disclosure statements will be included on a slide in each meeting room, as well as on the DIA 2017 website.
Americans with Disabilities Act (ADA)

Reasonable accommodations will be made available to persons with disabilities who attend an educational activity. Contact the DIA office in writing at least 15 days prior to event to indicate your needs.